Condition

Guillain Barré Syndrome clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Guillain Barré Syndrome clinical trials that are recruiting, at sites in 3 countries (most in Egypt (1), Italy (1), France (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Guillain Barré Syndrome clinical trials

StudyPhaseWhereStatusRegistered
Exploring the experiences of children who had Guillain-Barré Syndrome. — Montpellier, Occitanie and 1 other locations Recruiting Apr 23, 2025
High-tech rehabilitation program for adults with acute neuromuscular disease — Bari and 7 other locations Recruiting Feb 12, 2025
Using ultrasound to improve diagnosis of nerve disorders like GBS and CIDP — Asyut Recruiting Sep 26, 2024

All recruiting trials (3)

Related topics

Chronic Inflammatory Demyelinating PolyradiculoneuropathyCritical Illness MyopathyPeripheral Neuropathy

Quick answers

How many Guillain Barré Syndrome clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Egypt (1 trial), Italy (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.